BMS, Sanofi Stage $40 Mil. Roster Fight For Plavix DTC

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

Four agencies have emerged as finalists in a review for the estimated $40 million direct-to-consumer ad launch of Plavix, a prescription heart attack and stroke preventative, co-marketed by Bristol-Myers Squibb and Sanofi, sources said.
The clients confirmed the review but declined further comment. Sources said New York shops Robert A. Becker, Bozell Worldwide and Lieber, Levett, Koenig, Farese, Babcock, along with Quantum Consumer, a Parsippany, N.J.-based division of healthcare agency Thomas G. Ferguson & Associates, are the contenders.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in